Your browser doesn't support javascript.
loading
Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathology.
Subbian, Selvakumar; Tsenova, Liana; O'Brien, Paul; Yang, Guibin; Koo, Mi-Sun; Peixoto, Blas; Fallows, Dorothy; Zeldis, Jerome B; Muller, George; Kaplan, Gilla.
Affiliation
  • Subbian S; Laboratory of Mycobacterial Immunity and Pathogenesis, The Public Health Research Institute at the University of Medicine and Dentistry of New Jersey, Newark, NJ 07103, USA.
Am J Pathol ; 179(1): 289-301, 2011 Jul.
Article in En | MEDLINE | ID: mdl-21703411

Full text: 1 Database: MEDLINE Main subject: Thalidomide / Tuberculosis, Pulmonary / Cyclic Nucleotide Phosphodiesterases, Type 4 / Isoniazid / Lung / Macrophage Activation / Antitubercular Agents Type of study: Prognostic_studies Limits: Animals Language: En Journal: Am J Pathol Year: 2011 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Thalidomide / Tuberculosis, Pulmonary / Cyclic Nucleotide Phosphodiesterases, Type 4 / Isoniazid / Lung / Macrophage Activation / Antitubercular Agents Type of study: Prognostic_studies Limits: Animals Language: En Journal: Am J Pathol Year: 2011 Type: Article Affiliation country: United States